NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

An Ophthalmic Safety Study in Patients With Breast Cancer

NCT06767462

Active Not RecruitingN/A

Sponsor: AstraZeneca

Conditions: Ophthalmic Safety in Patients With Breast Cancer

Countries: United States, Argentina, Belgium, Brazil, Canada, Chile, Israel, Poland

To assess ophthalmic health in parallel cohorts of patients with breast cancer

Eligibility overview

Sex: ALL

Age: 18 Years to 130 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Signed informed consent in the qualifying study.
2. Signed informed consent in the ophthalmic study prior to any ophthalmic study specific assessments and procedures.
3. Completed the baseline ophthalmic examination for this study before the first dose in the qualifying study.
4. Meets all the eligibility criteria in the qualifying study

Exclusion Criteria:

1. Patients not randomized and not receiving study assigned treatment in a qualifying study.
2. Patients with contraindications to any ophthalmic procedure required by the study or sensitivity/allergy to pupil dilating agents.
3. Judgement by the investigator that the patient should not participate in the ophthalmic study if the patient is unlikely to comply with study procedures, restrictions, and requirements

Locations (50)

La Jolla, California, United States
Palo Alto, California, United States
Iowa City, Iowa, United States
Winston-Salem, North Carolina, United States
Clairton, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Sioux Falls, South Dakota, United States
Bartlett, Tennessee, United States
Houston, Texas, United States
CABA, Argentina
Córdoba, Argentina
Leuven, Belgium
Liège, Belgium
Alfenas, Brazil
Belo Horizonte, Brazil
Curitiba, Brazil
Lajeado, Brazil
Porto Alegre, Brazil
Pouso Alegre, Brazil
São Paulo, Brazil
Sorocaba, Brazil
Três Lagoas, Brazil
Vitória, Brazil
Montreal, Quebec, Canada
Montreal, Quebec, Canada
Santiago, Chile
Santiago, Chile
Ashdod, Israel
Nahariya, Israel
Lodz, Poland
+ 20 more on CT.gov